FAS and neoplasm: Different chemotherapies have been shown to stimulate the expression of death receptors on the surface of tumor cells (93), including FAS (also known as CD95), and TRAIL-R1 and TRAIL-R2 (also known as DR4 and DR5) on a large panel of cancer cells.